Acrivon Therapeutics, Inc. (ACRV) Tops Q1 EPS by 13c
Tweet
Share
E-mailGet Alerts ACRV Hot Sheet
Join SI Premium – FREE
Acrivon Therapeutics, Inc. (NASDAQ: ACRV) reported Q1 EPS of ($0.49), $0.13 better than the analyst estimate of ($0.62).
For earnings history and earnings-related data on Acrivon Therapeutics, Inc. (ACRV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Silver Lake In Talks To Buy Workday, Sources Say - Reuters
- Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating
- Apple opens Advanced Manufacturing Center in Houston for SMBs
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
